JPWO2023283550A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023283550A5 JPWO2023283550A5 JP2024500651A JP2024500651A JPWO2023283550A5 JP WO2023283550 A5 JPWO2023283550 A5 JP WO2023283550A5 JP 2024500651 A JP2024500651 A JP 2024500651A JP 2024500651 A JP2024500651 A JP 2024500651A JP WO2023283550 A5 JPWO2023283550 A5 JP WO2023283550A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid strand
- strand
- acid complex
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163218852P | 2021-07-06 | 2021-07-06 | |
| US63/218,852 | 2021-07-06 | ||
| PCT/US2022/073430 WO2023283550A1 (en) | 2021-07-06 | 2022-07-05 | Signal activatable nucleic acid complexes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024525647A JP2024525647A (ja) | 2024-07-12 |
| JP2024525647A5 JP2024525647A5 (https=) | 2025-07-14 |
| JPWO2023283550A5 true JPWO2023283550A5 (https=) | 2025-07-14 |
Family
ID=84802044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500651A Pending JP2024525647A (ja) | 2021-07-06 | 2022-07-05 | シグナルで活性化可能な核酸複合体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250257353A1 (https=) |
| EP (1) | EP4367245A4 (https=) |
| JP (1) | JP2024525647A (https=) |
| KR (1) | KR20240095155A (https=) |
| CN (1) | CN117916376A (https=) |
| AU (1) | AU2022308843A1 (https=) |
| CA (1) | CA3224950A1 (https=) |
| IL (1) | IL309943A (https=) |
| WO (1) | WO2023283550A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019014656A1 (en) | 2017-07-14 | 2019-01-17 | Han Si Ping | METALLIC OLIGONUCLEOTIDE JONCTIONS FOR THE ADMINISTRATION OF THERAPEUTIC AGENTS |
| EP3665281A4 (en) | 2017-08-10 | 2021-05-05 | City of Hope | CONDITIONAL SIRNA AND ITS USE IN THE TREATMENT OF CARDIAC HYERTROPHY |
| CN113166750B (zh) | 2018-08-10 | 2025-02-18 | 希望之城 | 可编程的条件性sirna及其用途 |
| CN116478410B (zh) * | 2023-06-20 | 2023-09-12 | 觅投克(北京)生物医学技术有限公司 | 一种菊糖修饰的聚乙烯亚胺衍生物及其制备方法和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6696285B1 (en) * | 1998-08-25 | 2004-02-24 | Lucent Technolgies Inc. | Nanomachines fueled by nucleic acid strand exchange |
| US9029524B2 (en) * | 2007-12-10 | 2015-05-12 | California Institute Of Technology | Signal activated RNA interference |
| US20100112556A1 (en) * | 2008-11-03 | 2010-05-06 | Sampson Jeffrey R | Method for sample analysis using q probes |
| US8710199B2 (en) * | 2010-06-23 | 2014-04-29 | California Institute Of Technology | Signal activated molecular delivery |
| US9725715B2 (en) * | 2011-06-23 | 2017-08-08 | California Institute Of Technology | Signal activatable constructs and related components compositions methods and systems |
| WO2013142735A1 (en) * | 2012-03-21 | 2013-09-26 | California Institute Of Technology | Targeting domain and related signal activated molecular delivery |
| US9856472B2 (en) * | 2013-07-01 | 2018-01-02 | California Institute Of Technology | Small conditional RNAs |
| WO2019033083A1 (en) * | 2017-08-10 | 2019-02-14 | City Of Hope | CONDITIONAL RNAIDS AND THEIR USES IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA |
| EP3665281A4 (en) * | 2017-08-10 | 2021-05-05 | City of Hope | CONDITIONAL SIRNA AND ITS USE IN THE TREATMENT OF CARDIAC HYERTROPHY |
| CN113166750B (zh) * | 2018-08-10 | 2025-02-18 | 希望之城 | 可编程的条件性sirna及其用途 |
-
2022
- 2022-07-05 CA CA3224950A patent/CA3224950A1/en active Pending
- 2022-07-05 KR KR1020247004152A patent/KR20240095155A/ko active Pending
- 2022-07-05 US US18/575,487 patent/US20250257353A1/en active Pending
- 2022-07-05 CN CN202280060504.5A patent/CN117916376A/zh active Pending
- 2022-07-05 EP EP22838546.4A patent/EP4367245A4/en active Pending
- 2022-07-05 WO PCT/US2022/073430 patent/WO2023283550A1/en not_active Ceased
- 2022-07-05 JP JP2024500651A patent/JP2024525647A/ja active Pending
- 2022-07-05 AU AU2022308843A patent/AU2022308843A1/en active Pending
- 2022-07-05 IL IL309943A patent/IL309943A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7406793B2 (ja) | ２テイル自己デリバリー型ｓｉＲＮＡおよび関連方法 | |
| US20220127609A1 (en) | Antisense oligonucleotides for nucleic acid editing | |
| JP2024019727A5 (https=) | ||
| CN102803284B (zh) | 用于miRNA抑制剂和模拟物的化学修饰基序 | |
| CN104245935B (zh) | 三环硫代磷酸酯dna | |
| JP2018516091A5 (https=) | ||
| CA2457528A1 (en) | Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina) | |
| JP2021519071A (ja) | シュードウリジン化のための核酸分子 | |
| TW202120689A (zh) | 用於降低PAPD5及PAPD7 mRNA以治療B型肝炎感染之核酸分子 | |
| KR20260007576A (ko) | 변형된 가이드 rna | |
| WO2018057575A1 (en) | Myostatin irna compositions and methods of use thereof | |
| JPWO2021216556A5 (https=) | ||
| JPWO2020206350A5 (https=) | ||
| JPWO2023283550A5 (https=) | ||
| JP7708659B2 (ja) | 小型化ヘアピンＲＮＡｉトリガー（ｍｘＲＮＡ）及びそれらの使用方法 | |
| JPWO2023283546A5 (https=) | ||
| JPWO2021119226A5 (https=) | ||
| JPWO2023049299A5 (https=) | ||
| JPWO2021195467A5 (https=) | ||
| WO2021157730A1 (ja) | 核酸医薬とその使用 | |
| JPWO2021188661A5 (https=) | ||
| CN116670276A (zh) | 用于通过多个靶标治疗疼痛的治疗组合物 | |
| US20220162606A1 (en) | Nrl expression reducing oligonucleotides, compositions containing the same, and methods of their use | |
| WO2025155911A1 (en) | Antisense oligonucleotides for the treatment of hurler syndrome | |
| WO2024220934A1 (en) | Nucleic acid molecules for pseudouridylation |